Home Top Movers Companies Concepts

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice

SCHEDULE 13G/A - Aligos Therapeutics, Inc. | StockGist | StockGist

Companies
ALGS
SCHEDULE 13G/A

Home Top Movers Companies Concepts

Home Filings ALGSSCHEDULE 13G/A

SCHEDULE 13G/A

Beneficial Ownership

Amendment

Aligos Therapeutics, Inc.

Filed Feb 11, 2026

Accepted Feb 11, 2026, 12:00 AM ET

CIK 0001799448

View on SEC.gov Company Profile

Beneficial Ownership Report

Passive Investment

Shares Owned

335,937

Reporting Person

Aligos Therapeutics, Inc.

Person Type

IA

CUSIP: 01626L204

Key Facts

Shares Owned

335,937

Recent Filings

Aligos Therapeutics, Inc.1 months ago

Aligos Therapeutics, Inc.1 months ago

Aligos Therapeutics, Inc.1 months ago

Aligos Therapeutics, Inc.2 months ago

Aligos Therapeutics, Inc.4 months ago

Data Sources

Original SEC Filing SEC EDGAR Company Page

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice